Akari Therapeutics Plc (AKTX) rose 34.07% or 2.01 to $7.91. It is about 18.61 million shares traded, which is 688.61% compare to the average total volume 2.70 million. The market cap of AKTX is $125.03 million. The year to date change is 288.42%. The 52 week price range is from $1.56 to $9.2. N/A N/A N/A 182.59% over last 6 months and 154.31% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKTX is 1.95. It is -75.35% below current price. The 200-day Moving Averages for AKTX is 1.93. It is -75.60% below current price. The 52-week High is 9.2. It is 16.31% from the current price. The 52-week Low is 1.56. It is -80.28% from current price.
There are some statistics of AKTX. It is has market cap $125.03 million. The share outstanding is 15.81 million. The average volume is 2.70 million. The percent of top 15 Institution holding is 13.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKTX is -261.01%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKTX is -143.99%.